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No previous publications evaluating longitudinal symptom growth or development of heterotypic 
comorbidity have appeared using data from this sample. Previous publications have addressed 
patterns of psychopathology at entry into the study, links between maternal nicotine exposure 
and children’s externalizing behaviors, and interactions between parenting practices and 
children’s autonomic nervous system responding.   
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Abstract 
Despite non-overlapping criterion sets, conduct disorder and depression co-occur at much higher 
rates than expected by chance. Contemporary model-based approaches to explaining heterotypic 
comorbidity use factor analysis and its variants to evaluate inter-relations among symptoms in 
large population-based and twin samples. These analyses invariably yield broadband 
internalizing and externalizing factors, which load on a higher-order general liability factor—
findings that are robust across age and informant. Although model-based approaches elucidate 
structural aspects of comorbidity, they are variable-centered, and usually cross-sectional. Most 
therefore do not assess developmental continuity of comorbidity, or whether non-comorbid 
individuals are prospectively vulnerable to heterotypic comorbidity. We use an accelerated 
longitudinal design to evaluate growth in parent-reported conduct problems (CPs) and depression 
among children, ages 8-15 years, who were recruited at study entry into depressed only (n=27), 
CPs only (n=28), comorbid (n=81), and control (n=70) groups based on levels of symptoms. 
Consistent with normative developmental trends across this age range, steep growth in 
depression was exhibited by all groups, including those who reported only CPs at study entry. In 
contrast, growth in CPs was restricted to those who reported high symptoms at intake (with or 
without comorbid depression), compared with low and stable among depressed only and control 
participants. To our knowledge, this is the first study to demonstrate, using carefully ascertained 
“pure” versus comorbid groups who were followed naturalistically, that comorbid depression is 
likely to develop among those with pure CPs,  but comorbid CPs are not likely to develop among 
those with pure depression.  
Keywords: conduct disorder, depression, comorbidity, heterotypic, development 
General Scientific Summary: This study indicates that children who experience conduct 
problems early in life are just as vulnerable as other children to developing depression in 
adolescence. In contrast, children who experience depression are not vulnerable to developing 
conduct problems in adolescence. These findings may be useful for helping us understand shared 
causes of different disorders, and for assigning children to appropriate treatments.   
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Comorbidity and Continuity of Depression and Conduct Problems  
from Elementary School to Adolescence 
Traditionally, most psychiatric disorders of childhood and adolescence have been viewed as 
either distinct diagnostic entities, as exemplified in the Diagnostic and Statistical Manual of 
Mental Disorders (American Psychiatric Association, 2013), or as variants along factor 
analytically-derived internalizing or externalizing dimensions (Achenbach & Edelbrock, 1983, 
1991). When following the DSM-perspective, differential diagnosis is prioritized, which 
sometimes obscures common etiological mechanisms among internalizing disorders and among 
externalizing disorders (see e.g., Beauchaine, Zisner, & Sauder, 2017; Tackett et al., 2013). Even 
empirically-based taxonomies, such as the Child Behavior Checklist (Achenbach & Edelbrock), 
which acknowledge shared liability within the internalizing and externalizing spectra, can reify—
however unwittingly—distinctions between internalizing and externalizing disorders. In recent 
years it has become clear that strong distinctions between and among internalizing and 
externalizing disorders are not always warranted (see e.g., Beauchaine & Constantino, 2017; 
Zisner & Beauchaine, 2016), and that transdiagnostic vulnerabilities to psychopathology extend 
both within and across the internalizing and externalizing spectra (e.g., Krueger, 1999; Lahey, 
Van Hulle, Singh, Waldman, & Rathouz, 2011; Lahey, Krueger, Rathouz, Waldman, & Zald, 
2017; Tackett et al., 2013). As a result, both homotypic comorbidity (co-occurrence of either 
multiple internalizing or multiple externalizing disorders within individuals) and heterotypic 
comorbidity (co-occurrence of both internalizing and externalizing disorders within individuals) 
are observed at rates that far exceed those expected by chance (Angold, Costello, & Erkanli, 
1999; Costello, Mustillo, Erkanli, Keeler, & Angold, 2003; Gilliom & Shaw, 2004; Keiley, 
Bates, Dodge, & Pettit, 2000; Kessler et al., 1994; Klein & Riso, 1993; Merikangas et al., 2010).  
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Although both homotypic and heterotypic comorbidity are common, etiological mechanisms 
are not fully understood (Beauchaine & Cicchetti, 2016). In this article, we explore longitudinal 
patterns of symptom development from ages 8-15 years among children who were recruited at 
study entry for “pure” externalizing behaviors, “pure” internalizing behaviors, comorbid 
internalizing and externalizing behaviors, and no psychiatric symptoms. As outlined below, 
comparing symptom development among contrasted groups provides certain advantages for 
addressing questions about shared versus specific etiologies of internalizing and externalizing 
behaviors. To our knowledge, this is the first study to date that examines longitudinal patterns of 
symptom development among contrasted groups recruited from the community and followed 
naturalistically. Other studies have evaluated comorbidity and continuity of internalizing and 
externalizing behaviors among treatment-seeking samples, which differ from more naturalistic 
samples in initial levels of functional impairment, symptom severity and duration, rates of 
comorbidity, and exposure to intervention (Goodman et al., 1997). Thus, longitudinal courses of 
their symptom profiles likely differ from those of untreated samples. Before describing study 
procedures, we first review contemporary structural accounts of comorbidity, and then consider 
how contrasted groups designs complement rather than compete with model-based approaches.   
Hierarchical Latent Structure of Internalizing and Externalizing Behaviors 
Model-based, structural approaches to characterizing psychopathology apply factor analysis 
and its variants to symptoms expressed among large population-based samples or twin registries. 
Such analyses almost invariably yield (1) a broadband internalizing factor that accounts for a 
preponderance of covariation among first-order syndromes including anxiety, depression, and 
withdrawal (this factor is sometimes parsed further into fear and distress); (2) a broadband 
externalizing factor that accounts for a preponderance of covariation among first-order 
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syndromes including impulsivity, delinquency, and overt aggression, and (3) a higher-order 
general liability factor that both the internalizing and externalizing factors load on, and accounts 
for considerable covariation between internalizing and externalizing syndromes (e.g., Lahey et 
al., 2012). In an era of non-replication (see Tackett et al., 2017), this bifactor latent structure is 
remarkably consistent, as evidenced by convergence across child, adolescent, and adult samples; 
male, female, and mixed samples; and self-, parent-, and teacher-reports of symptoms (e.g., 
Caspi et al., 2014; Lahey et al., 2011, 2014; Olino, Dougherty, Bufferd, Carlson, & Klein, 2014; 
Tackett et al., 2013). Furthermore, high scores on the general liability factor predict poor 
concurrent and prospective function across diverse settings for both children and adults (e.g., 
Caspi et al., 2014; Lahey et al., 2014; Martel et al., 2017).   
Bifactor model-fitting—especially given such consistent results—offers several advantages 
for furthering our understanding of comorbidity. First, it suggests transdiagnostic etiological 
influences for internalizing and externalizing disorders. Only a decade ago, such interpretations 
enjoyed little support. Now, however, evidence of shared etiology is substantial, and includes (1) 
common genetic influences for internalizing and externalizing disorders (e.g., Cosgrove et al., 
2011); (2) common genetic influences for general liability to psychopathology and negative 
emotionality—a personality trait that characterizes both internalizing and externalizing disorders 
(e.g., Tackett, Waldman, Van Hulle, & Lahey, 2011; Tackett et al., 2013); and (3) central 
nervous system accounts of internalizing and externalizing behavior that link both to common 
neural substrates of anhedonia/negative affectivity (Beauchaine & Constantino, 2017; Zisner & 
Beauchaine, 2016). Thus, bifactor models have yielded refinements in both theory and research, 
and ushered in new ways of thinking about comorbidity (Beauchaine & Zisner, 2017; Carver, 
Johnson, & Timpano, 2017; Forbes, Tackett, Markon, & Krueger, 2016).  
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Limits of Structural Models 
A major strength of model-based approaches is that they provide—by reducing vast amounts 
of data—a single representation that best characterizes patterns of covariance among symptoms 
in the population. When derived from twin samples, structural models also inform us about 
heritability (e.g., Tackett et al., 2013). Thus, they are parsimonious, powerful statistically, and, as 
noted above, yield insights into etiology. Nevertheless, structural models can be insensitive to 
etiological heterogeneity, especially when such heterogeneity characterizes low base rate 
subgroups within the larger population. As reviewed by Plichta and Scheres (2014), for example, 
etiological mechanisms of impulsivity—a core vulnerability to externalizing disorders 
(Beauchaine et al., 2017; Mann et al., 2017)—may differ when the trait is manifested in normal 
personality versus psychopathology. In such situations, unique patterns of symptom covariance 
among psychopathological subgroups can be swamped by ordinary variation in symptoms (for 
further discussion see Shader et al., 2017). Similarly, etiologically meaningful subtypes of 
psychopathology may not be captured by an otherwise well-fitting structural model. For 
example, studies of externalizing behavior identify subsets of delinquent children and adults who 
display very little anxiety (see e.g., Beauchaine et al., 2017). This low base rate presentation 
responds poorly to treatment, and has been linked to risk for psychopathy (Frick, Ray, Thornton, 
& Kahn, 2014; Herpers, Scheepers, Bons, Buitelaar, & Rommelse, 2014). Thus, externalizing 
behaviors in the absence of internalizing symptoms—which are not well accounted for by 
population-based structural models—are diagnostically and prognostically meaningful. 
Finally, most bifactor models conducted to date have been cross-sectional, and therefore do 
not evaluate continuity or change in patterns of symptoms—including homotypic continuity, 
heterotypic continuity, or emerging or diminishing comorbidity among individuals over time (for 
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exceptions see Caspi et al., 2014 and Forbes et al., 2016; Lahey et al., 2017). It is possible and 
perhaps even likely, for example, that some children with conduct problems never develop 
internalizing symptoms, and that some children with depression never develop conduct 
problems. Individual differences in longitudinal courses of symptoms often have implications for 
validating distinctions among heterogeneous subgroups, and for developing effective prevention 
and intervention programs (e.g., Robins & Guze, 1970).Such results would complement findings 
from model-based approaches, improving our understanding of etiological heterogeneity.   
Comorbidity and Continuity in Longitudinal Samples 
In addition to homotypic comorbidity, defined by multiple internalizing or multiple 
externalizing disorders within individuals (see above), homotypic continuity, defined by 
longitudinal progression of either internalizing or externalizing psychopathology across 
childhood and adolescence, is well documented (e.g., Beauchaine & McNulty, 2013; Cicchetti & 
Natsuaki, 2014; Cicchetti, Rogosch, & Toth, 1997; Hinshaw, 2015; Moffitt, 1993). Neither 
concurrent comorbidity nor homotypic continuity within internalizing or externalizing disorders 
is surprising given within-spectrum overlap of symptoms, personality characteristics, and both 
genetic and neural vulnerabilities (Beauchaine & Cicchetti, 2016; Tackett et al., 2011, 2013).   
Notably, heterotypic continuity (sometimes called sequential comorbidity) between 
internalizing and externalizing disorders—a primary focus of this article—is also common, but is 
more difficult to explain given almost no overlap in symptoms. Nevertheless, both CPs and 
depression in childhood confer prospective vulnerability to one another in adolescence (e.g., 
Gilliom & Shaw, 2004; Kovacs, Paulauskas, Gatsonis, & Richards, 1988; Zoccolillo, 1992). In a 
recent meta-analysis of longitudinal studies comprising 17,712 children ages 12 years or below 
at initial assessment, Loth, Drabick, Leibenluft, and Hulvershorn (2014) found that childhood 
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externalizing disorders predicted adult depression in most studies, and in the sample as a whole. 
Among preschool children, externalizing behaviors also predict later growth in internalizing 
symptoms (Gilliom & Shaw, 2004). In contrast, others have demonstrated the opposite pattern, 
whereby internalizing disorders predict later CPs. Drabick, Gadow, and Sprafkin (2006), for 
example, reported that depressive symptoms predicted future conduct disorder among 6-10-year-
old boys with ADHD. Early-onset internalizing and externalizing disorders predicting later onset 
of one another is of course expected if both arise from a common etiology (see above). 
Strengths and Limitations of Existing Longitudinal Studies 
To date, almost all studies that have evaluated heterotypic continuity of CPs and depression 
have done so using treatment-seeking samples with high levels of pre-existing comorbidity, 
rather than recruiting carefully ascertained comorbid and non-comorbid groups. On the one hand, 
comorbidity is characteristic of those who seek intervention, and may represent the bulk of those 
affected by internalizing and externalizing psychopathology (see above). Thus, results are likely 
generalizable to a large proportion of treatment-seeking people. Yet such generalizability comes 
at a cost. In attempting to disentangle heterotypic trajectories in symptoms among highly 
comorbid samples, lagged correlations (or similar statistical partialling approaches) must be used 
to establish prediction of CPs by depression versus prediction of depression by CPs. For 
example, one might determine whether depression at age 8 years predicts CPs at age 12, over-
and-above CPs at age 8. Although this approach has intuitive appeal, statistical partialling is 
problematic whenever two disorders share a common etiology. If depression and CPs arise either 
partly or fully from transdiagnostic vulnerability (see Zisner & Beauchaine, 2016; Tackett et al., 
2013), that very vulnerability is “partialled out” of the prediction equation. As a result, statistical 
partialling may obscure longitudinal relations between disorders when “controlling for” or 
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“partialling out” etiologically related conditions (Beauchaine, Hinshaw, & Pang, 2010). This 
situation is depicted in Figure 1. As reviewed by Miller and Chapman (2001), when two 
assumedly different disorders share symptoms, psychological vulnerabilities, and neural 
substrates, statistical partialling creates mathematical entities that may misrepresent/distort 
etiological relations between variables.  
Following from this discussion, we sought to complement knowledge gleaned from structural 
models of comorbidity and previous longitudinal studies by evaluating—using an accelerated 
longitudinal design—patterns of heterotypic comorbidity and continuity in depression and CPs 
from ages 8-15 years among children who were recruited at study entry into depressed-only, 
CPs-only, heterotypically comorbid, and non-psychiatric control groups. We hypothesized that 
(1) those recruited for non-comorbid CPs would show continued growth in CPs, (2) those 
recruited for non-comorbid depression would show continued growth in depression, and (3) 
those recruited for pre-existing comorbidity would show continued growth in both internalizing 
and externalizing symptoms over time. Confirmation of these hypotheses would suggest that 
non-comorbid CPs and depression have potentially important prognostic value that has not been 
captured definitively by existing research. We included a non-psychiatric control group to ensure 
that any changes in symptoms could be indexed to normative growth in CPs and depression.  
Method 
Participants 
Participants were recruited using advertisements placed in local newspapers, community 
publications, and city buses. To recruit the clinical groups, these advertisements described 
characteristics of depression and CPs, and asked interested parents to call if they felt that their 
child fit one or both descriptions. Separate advertisements seeking “well adjusted” children were 
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used to recruit non-psychiatric control participants  We received 445 inquiries from parents who 
completed (1) a 30-min computerized, structured phone interview including DSM-IV-TR 
(American Psychiatric Association, 2000) major depressive disorder (MDD), dysthymia (DYS), 
ADHD, oppositional defiant disorder (ODD), and CD subscales from the Child Symptom 
Inventory (CSI-4; Gadow & Sprafkin, 1997); and (2) the anxious/depressed, aggression, and 
attention problems subscales from the Child Behavior Checklist (CBCL; Achenbach & 
Edelbrock, 1983, 1991). Child-Symptom Inventory-4 items are assessed on 4-point scales (0 = 
never, 1 = sometimes, 2 = often, 3 = very often), with scores of 2 and 3 considered positive for 
each diagnostic criterion. Scores can also be summed dimensionally. In this study, we use 
dimensional scores for our primary analyses (described below), but we also report tentative 
diagnoses. Details regarding reliability and validity of these measures appear below. Responses 
were scored immediately by computer.  
Based on these interviews, 212 children were assigned into the following four groups: 
conduct problems (CPs; n=28), depression (DEP; n=27), comorbid (CMB; n=81) and control 
(CTR; n=70). To be included in the CPs group, children were required to meet DSM-IV criteria 
for ODD and/or CD on the CSI, and/or score at or above the 98th percentile (T≥70) on the CBCL 
aggression subscale. They could not meet criteria for depression or dysthymia, and were required 
to score T≤60 on the CBCL anxious/depressed subscale. To be included in the DEP group, 
children were required to meet DSM-IV criteria for major depression or dysthymia on the CSI, 
and/or score at or above the 98th percentile (T≥70) on the CBCL anxious/depressed subscale. 
They could not meet criteria for CD or ODD, and were required to score T≤60 on the CBCL 
aggression subscale. Children in the CMB group were required to meet criteria for both the CPs 
and DEP groups, with no CBCL exclusions. Finally, children in the CTR group had to be free of 
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psychiatric diagnoses on all CSI scales, and score T≤60 on all CBCL subscales. Additional 
exclusion criteria included symptoms of psychosis, autism, or intellectual disability, as assessed 
during the structured phone interview. Of the 212 qualifying participants, 6 dropped out early 
and did not attend any lab sessions (described below). The final sample was therefore comprised 
of 206 children, including 134 boys and 72 girls. Racial composition was 61.7% Caucasian, 
12.1% African American, 10.2% Hispanic, 6.3% Asian American, (2.4% Pacific Islander, 1.5% 
American Indian. The remaining 5.8% either entered a race other than those listed above, or 
declined to respond.	Annual income averaged $50,550, which falls slightly below median US 
household income, but nearly $30,000 below median Seattle household income. Of note, 
$72,000 is the low income threshold for a family of four in King County, WA (US Department 
of Housing and Urban Development, 2017).  
Procedure 
All procedures were approved by the local institutional review board (approval number 01-
358), and researchers obtained parental consent and child assent prior to each yearly lab session 
(see below). Following the structured phone interview in which parents completed the CSI-4 and 
CBCL, those who met inclusion criteria were invited to the lab for their first of three annual 
assessments (Year 1). As described in detail elsewhere (e.g., Kopp & Beauchaine, 2007), these 
assessments included collection of additional questionnaires and participation in a broader lab 
protocol that is not relevant to the current paper (see Beauchaine, Hong, & Marsh, 2008; 
Shannon, Beauchaine, Brenner, Neuhaus, & Gatzke-Kopp, 2007; Vasilev et al., 2009). Similar 
assessments were conducted at Years 2 and 3, when CSI-4, CBCL, and laboratory tasks were 
again administered. Parents were compensated $75 for participation at each annual assessment.  
Measures 
HOMOTYPIC AND HETEROTYPIC COMORBIDITY AND CONTINUITY  12 
Child Symptom Inventory for DSM-IV (CSI-4; Gadow & Sprafkin, 1997). As described 
above, the CSI-4 assesses a wide range of DSM-IV psychiatric disorders of childhood. Parents 
completed the CD, ODD, ADHD, MDD, and dysthymia modules at each time point. Sensitivities 
and specificities vis-à-vis clinical diagnoses for the CSI scales used in this study range from .73 
to .83, suggesting adequate validity (Gadow & Sprafkin, 1997). Reliabilities, as assessed via 
Cronbach’s α coefficients calculated at each yearly assessment ranged from .85-.90.  
Child Behavior Checklist (CBCL; Achenbach, & Edelbrock, 1991). At Year 1, parents 
completed the anxious/depressed, aggression, and attention problems subscales of the CBCL for 
group assignment purposes (see above). Cronbach’s αs ranged from .90-.93. 
Analyses 
Among the 206 children who were assigned to groups, 28 (13.6%) dropped out before Year 
2, and 20 (9.7%) dropped out before Year 3. Participants who dropped out scored higher on all 
CSI and CBCL scales. Rather than omitting these participants, which would have introduced bias 
into outcomes and analyses, we imputed their data in SPSS 241. Analyses were conducted across 
30 imputations, according to established guidelines (see Graham, 2009).   
We assessed growth in depressive symptoms by constructing multilevel models in 
Hierarchical Linear Modeling software, version 6.08 (HLM; Raudenbush, Bryk, & Congdon, 
2004). Within-participant change in parent-reported depressive symptoms was modelled across 
age rather than timepoint at Level 1. This enabled us to evaluate symptom trajectories across the 
entire 8-year age span. As with all accelerated longitudinal designs, the sample size was 
																																								 																				
1Debate has existed for some time in the literature regarding use of multiple imputation (MI) versus full-information 
maximum likelihood (FIML) estimation to replace missing data (e.g., Shin, Davison, & Long, 2017). Structural 
equation modeling programs often use FIML, whereas many statistics packages use MI (SAS provides both 
options). Although FIML sometimes outperforms MI when the number of imputations (m) is small, the procedures 
are equivalent when m is large (Graham, Olchowski, & Gilreath, 2007). Accordingly, we used 30 imputations (as 
few as 5 are typical). With large numbers of imputations, Monte Carlo studies show comparable parameter estimates 
for MI and FIML under a wide range of missing data conditions (Dong & Peng, 2013).      
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somewhat smaller at age extremes (n = 51 at age 8, n = 81 at age 9, n = 123 at age 10, n = 111 at 
age 11, n = 117 at age 12, n = 73 at age 13, n = 47 at age 14, and n = 13 at age 15). Age at Year 1 
was entered at Level 2 to control for individual differences at entry into the accelerated 
longitudinal design. Group differences in growth of depression were assessed by entering 
orthogonal contrast codes at Level 22. Contrast 1 (C1) compared the CTR group to all clinical 
groups, Contrast 2 (C2) compared the CMB group to the DEP and CPs groups, and Contrast 3 
(C3) compared the DEP and CPs groups. Sex effects were evaluated as a possible covariate at 
Level 2 given well-documented sex differences in growth of depression across this age range 
(e.g., Nolen-Hoeksema, 1987; Kendler & Gardner, 2014). The full model for DSM depressive 
symptoms was as follows: 
Level 1: depression/dysthymia symptomsti =π0i + π1i*(ageti) + eti 
Level 2:  π0i = β00 + β01*(sexi) + β02*(C1i) + β03*(C2i) + β04*(C3) + β05*(ageTime1) + r0i 
π1i = β10 + β11*(sexi) + β12*(C1i) + β13*(C2i) + β14*(C3i) + β15*(ageTime1) + r1i 
 
Note that we specify depression/dysthymia symptoms together since DSM-IV dysthymia 
symptoms and DSM-IV major depression symptoms are largely overlapping. We therefore 
combined modules. Next, to evaluate growth in CPs, we ran a parallel model with DSM conduct 
disorder (CD) symptoms as the outcome. For both sets of analyses, we restricted outcomes to 
symptoms of DSM disorders (depression, CD), since almost all of the existing literature on 
heterotypic comorbidity and continuity has done so. This enabled us to compare results to 
previously reported findings. Finally, we evaluated growth in ODD symptoms, as requested by 
an anonymous reviewer.    
Results 
																																								 																				
2Orthogonal contrast codes were constructed to ensure that all contrasts were independent, and to control for size 
differences between groups. Orthogonal coding provides numerous statistical advantages over other approaches, 
including lower probability of Type I error (see e.g., Pedhazur, 1997). 
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Descriptive Statistics 
Descriptive statistics at study entry are reported by group in Table 1. As described in detail 
elsewhere (e.g., Vasilev et al., 2009), recruitment was effective in yielding groups with 
significant differences of large effect size across all measures of psychopathology, all Fs (3,203) 
≥ 23.8, all ps <.001, all η2 ≥ .23.  
Growth in (1) depressive/dysthymic symptoms and (2) CD and ODD symptoms across Years 
1-3 are reported in Tables 2 and 3, respectively. Table 2 includes mean symptom levels and 
percentages of those who met DSM-IV criteria for MDD and/or dysthymia at each assessment, 
and Table 3 includes mean levels of and percentages of those who met DSM-IV criteria for CD 
and at each assessment. Significant symptoms of both depression and CD persisted across time, 
as reported in detail below.		
Results from all of the multilevel models evaluating growth (slopes) in depressive symptoms, 
CD symptoms, and ODD symptoms are summarized in Table 4. Uncentered intercept effects are 
also reported. Given the complexity of the three models, we discuss specific findings for 
depressive symptoms as outcomes (top third of Table 4), CD symptoms as outcomes (middle 
third of Table 4), and ODD symptoms as outcomes (bottom third of Table 4) separately below. 
Growth in Depression 
In a preliminary HLM model without contrast codes, age predicted Level-1 slopes in parent-
reported depressive symptoms, b = 0.59, t(204) = 6.22, p < 001. Thus, symptoms of depression 
increased over time sample-wide. Given the age range of the sample, normative growth in 
depression should be expected (e.g., Garber, Keiley, & Martin, 2002). Interestingly, however, 
when entered as a Level 2 fixed effect, sex did not predict growth in depressive symptoms, b = -
0.035, t(200) = -1.302, p = .195. This is not entirely surprising given that so many participants 
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were recruited specifically for having high depression scores—regardless of sex. 
Level 2 orthogonal contrasts comparing growth in depression across groups were evaluated 
next. The contrast comparing the non-psychiatric control group to all three clinical groups (C1) 
indicated steeper growth in depressive symptoms among controls than among the three clinical 
groups, b = -0.0003, t(200) = -2.580, p = .011. Growth in depression for all groups is depicted in 
Figure 1. As this finding indicates, children who were free from depression at study entry 
showed marked growth in symptoms from middle school to adolescence. Again, such findings 
are expected in this age range (e.g., Garber et al., 2002). Nevertheless, controls’ overall level of 
depression was lower across the assessment period, as indicated by a significant mean-centered 
intercept for C1, b = 0.003, t(201) = 10.44, p <.001 (this intercept is not reported in Table 4, 
which lists uncentered intercepts). 
The next contrast, which compared the CMB group to the CP and DEP groups (C2), 
approached significance, b = 0.0004, t(200) = 1.900, p = .058. This indicates steeper growth in 
depressive symptoms among the CP and DEP groups than among the CMB group. As Figure 1 
illustrates, this finding is almost certainly attributable to a ceiling effect, since CMB participants 
were the most symptomatic across the entire age range.   
The final contrast (C3), which compared the CP and DEP groups, was not significant, b = -
0.001, t(200) = -1.186, p = .238. Thus, there was no difference in growth in depression between 
children with CPs only at study entry vs. those with depression/dysthymia only. Notably, 
however, both groups exhibited steep increases in depressive symptoms from ages 8-15 years. 
Finally, to confirm that CPs only were associated with development of depression, we 
evaluated the slope effect for the CPs only group. This analysis indicated significant growth in 
depression from ages 8 to 15 among those recruited for CPs only, b = 0.80, t(26) = 3.62, p = .001 
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(this is not reported in Table 4). Thus, CPs alone were associated with growth in depression that 
was similar to that observed in the depression only group.      
Growth in Conduct Problems 
Next, we assessed group differences in parent-reported CD symptom growth from ages 8-15 
years. As with depressive symptoms, age predicted slopes in CD symptoms at Level 1 in a 
preliminary model without contrast codes, b = 0.39, t(205) = 7.55, p < 0.001. Thus, CD 
symptoms increased over time sample-wide.  As with depression, this is not entirely surprising 
given normative developmental increases in CD symptoms across this age range—particularly 
adolescent-onset symptoms (e.g., Moffitt, 1993). When entered as a Level 2 fixed effect, sex did 
not predict growth in CD symptoms, b= -0.196, t(200) = -1.192, p = .235. This is not unexpected 
given that many participants were recruited based on CD symptoms, regardless of sex. 
The contrast comparing non-psychiatric controls to all clinical groups (C1) indicated steeper 
growth in CD symptoms by the control group than the three clinical groups, b = -0.002, t(200) = 
-2.932, p = .004. Growth in CD symptoms for all groups is depicted in Figure 2. Despite sample-
wide growth, CD symptoms were lower overall among non-psychiatric controls than the clinical 
groups, as confirmed by a significant mean-centered intercept of C1, b = -0.002, t(201) = -2.71, p 
= .008 (not reported in Table 4). The next contrast, which compared the CMB group to the CP 
and DEP groups (C2), was also significant, b = 0.003, t(200) = 2.030, p = .043. Participants in 
the CP and DEP groups showed steeper growth in CD symptoms than those in the CMB group 
(see Figure 2).  
The final contrast (C3), which compared the CPs and DEP groups, was not significant, b = 
0.007, t(200) = 1.296, p = .197. Thus, the CPs and DEP groups showed similar growth rates in 
CD symptoms. However, the CPs group exhibited much higher levels of CD symptoms across 
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the entire age range than the DEP group, which exhibited very few symptoms (see Figure 2). 
This difference in overall levels of CD symptoms was confirmed by a significant mean-centered 
intercept for C3, b = -0.15, t(200) = -2.84, p = .006 (not reported in Table 4)3.  
To assess whether depression alone was associated with development of CPs, we evaluated 
the slope effect for the depression only group (not reported in Table 4). This analysis indicated 
no growth in CPs from ages 8 to 15 years among those recruited for depression only, b = -0.74, 
t(25) = -0.86, p = .40. Thus, depression alone was not associated with growth in CPs. We also 
evaluated the slope effect for controls only (not reported in Table 4), who also exhibited no 
growth in CD symptoms, b = -0.19, t(68) = -0.83, p = .41. We discuss these findings in greater 
detail below.   
Growth in Oppositionality 
Finally, we evaluated growth in ODD symptoms across groups. Doing so was important for 
at least two reasons. First, ODD often emerges before CD in longitudinal progressions of 
externalizing behavior (see Beauchaine & McNulty, 2013; Beauchaine et al., 2017). Thus, ODD 
symptoms may portend vulnerability to CD, and may be a more sensitive indicator of emerging 
externalizing problems than CD symptoms. Second, ODD is associated with high levels of 
irritability and negative emotionality, and predicts development of depression (see Burke, 
Hipwell, & Loeber, 2010; Burke & Loeber, 2010; Herzhoff & Tackett, 2015). Thus, ODD 
portends vulnerability to both CD and depression, and is marked by the very personality trait—
persistent negative emotionality—that accounts for common heritable variance in internalizing 
and externalizing behaviors (Tackett et al., 2013) and derives from well-articulated neural 
																																								 																				
3At the request of the action editor, we also evaluated growth in aggressive vs. non-aggressive symptoms of CD 
separately. In these analyses, the CSI-4 CD subscale was partitioned into aggressive (DSM-IV symptoms 1-7) and 
non-aggressive (DSM-IV symptoms 8-15) criteria. No significant group differences in slopes emerged from either 
analysis. Thus, aggressive and non-aggressive symptoms of CD demonstrated additive rather than independent 
effects. 
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substrates (Zisner & Beauchaine, 2016).  
As with depressive and CD symptoms, age predicted slopes in ODD symptoms at Level 1 in 
a preliminary model without contrasts codes, b = 2.88, t(204) = 3.11, p = .002. Thus, ODD 
symptoms increased over time sample-wide. The Level 2 sex effect was not significant, b = 
0.018, t(200) = 0.069, p = .946. Once again, this is not surprising since so many participants 
were recruited based on ODD symptoms, regardless of sex. 
The contrast comparing control participants to all clinical groups (C1) indicated steeper 
growth in ODD symptoms among non-psychiatric controls than the three clinical groups, b = -
0.005, t(200) = -4.282, p < .001. Growth in ODD symptoms for all groups is depicted in Figure 
3. Importantly, despite their steeper slope, controls exhibited overall lower ODD symptoms than 
the clinical groups, as indicated by a significant mean-centered intercept for C1, b = 0.03, t(201) 
= 12.50, p < .001 (not reported in Table 4). The next contrast (C2), which compared the CMB 
group to the CP and DEP groups, was not significant, b = 0.004, t(200) = 1.923, p = .056.  
Similarly, the final contrast (C3), which compared the CP and DEP groups, was not 
significant, b = 0.013, t(200) = 1.661, p = .098. Thus, both groups showed similar growth rates in 
ODD symptoms. Notably, however, the mean-centered intercept for C3 was significant, 
indicating greater ODD symptoms for the CPs group than the DEP group from ages 8-15, b = -
0.26, t(200) = -3.04, p = .003 (not reported in Table 4).  
We ran one additional, unplanned contrast to determine whether growth in ODD symptoms 
differed for the DEP only versus CTR groups. The slope parameter was not significant, b = -
0.007, t(203) = -1.65, p = .10. Thus, growth in ODD symptoms was indistinguishable between 
depressed participants and non-psychiatric controls.    
Discussion	
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We sought to disentangle—to the extent possible with parent-report data—whether early 
depression confers vulnerability to later CD, early CPs confer vulnerability to later depression, or 
both. Although our findings do not answer these questions fully, they do help to clarify the 
existing literature. Below we consider findings specific to depression, CD, and ODD symptoms 
in turn, before presenting a more general discussion.  
First, similar growth rates in depression were observed for all groups, including those 
recruited for CPs only and no psychiatric symptoms at study entry. As noted above, growth in 
depression is expected in this age range (Garber et al., 2002; Nolen-Hoeksema, 1987; Kendler & 
Gardner, 2014), so these findings aren’t entirely surprising—except perhaps for the CPs-only 
group. Several authors have proposed that CPs in the absence of internalizing symptoms mark a 
more virulent, treatment-resistant phenotype that portends vulnerability to future psychopathy 
(e.g., Frick et al., 2014; Herpers et al., 2014). This perspective is often rooted in trait-based 
assumptions that would not predict longitudinal increases in depression among children recruited 
for CD-only. Our findings suggest that CPs without depression do not identify a subgroup of 
children who are invulnerable to heterotypic comorbidity and continuity. In all likelihood, 
assessment of additional constructs—most notably callous-unemotional traits—would be 
required to identify such individuals (e.g., Golmaryami & Frick, 2017). Our findings indicate 
that children with “pure” CPs are just as vulnerable to depression as other high-risk groups.   
It is also notable that (a) children recruited for high levels of depression (98th percentile vis-
à-vis national norms) continued to show worsening symptoms over time, and (b) CMB 
participants showed the highest levels of symptoms across the entire age range. The latter finding 
in particular suggests that heterotypic comorbidity is unlikely to relent from ages 8-15. It is 
troubling that depressed adolescents with comorbid CD are especially vulnerable to suicidal 
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behaviors (Nock, Hwang, Sampson, & Kessler, 2010). Although we did not measure suicidal 
behavior in this study, our findings of continuity in (and perhaps amplification of) heterotypic 
comorbidity suggest that early diagnosis may be useful for prevention.  
Longitudinal trajectories in CD symptoms were more differentiated. Although sample-wide 
increases in symptoms were observed, these increases were driven entirely by those in the CPs 
and CMB groups, who, despite being recruited for high levels of CD symptoms, developed 
worsening externalizing behavior over time. In contrast, those in the DEP-only and non-
psychiatric control groups exhibited no growth in CD symptoms from ages 8-15. This finding 
indicates that pure depression does not confer vulnerability to CPs, thereby clarifying a 
longstanding controversy in the literature. Importantly, this question could not have been 
resolved by applying statistical control techniques to highly comorbid samples (Beauchaine et 
al., 2010; Miller & Chapman, 2001). Such studies suggest that CD portends vulnerability to later 
depression and that depression portends vulnerability to later CPs (e.g., Drabick et al., 2006; 
Gilliom & Shaw, 2004; Loth et al., 2014). By using a contrasted groups design, we demonstrated 
that pure CPs follow a heterotypic developmental pathway, whereas pure depression does not. 
We note, however, that both depression and CD are dimensional constructs in nature, so we had 
to impose relatively strict yet arbitrary cutoffs to create these “pure” groups. 
Oppositional symptoms demonstrated an “intermediate” growth pattern. Similar to 
depressive symptoms, increases in ODD were observed across the sample, despite recruitment 
based on high (CPs, CMB) versus low (DEP, CTR) symptoms at study entry. Yet similar to CD 
symptoms, lower levels of ODD were observed in the control and DEP groups across the entire 
age range. Furthermore, growth in ODD symptoms was similar among DEP and non-psychiatric 
control participants. This indicates age-normative increases in ODD symptoms rather than 
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pathological growth trajectories among those with pure depression. Thus, those with pure 
depression exhibited normal growth patterns in both ODD and CD.  
In considering findings collectively, heterotypically comorbid participants appear to be most 
impaired—as expected given our recruitment strategy. Heterotypically comorbid participants 
showed (1) persistently high rates of CD symptoms across elementary school to mid-
adolescence, (2) growth in depression across the same time span, and (3) the highest rates of 
depressive symptoms at every age evaluated. These children and adolescents therefore appear to 
be worse off than any of their peers—at least in terms of symptoms. This is consistent with the 
existing literature, which indicates that individuals with comorbid depression and CD show more 
severe symptoms of both disorders than individuals with either disorder alone (e.g. Ezpeleta, 
Domenech, & Angold, 2006; Marmorstein & Iaocono, 2003).  
It is important to note, however, that symptoms are not the only metric for evaluating 
impairment. For example, comorbid internalizing symptoms predict better responses to 
behavioral treatments for CD (Beauchaine, Webster-Stratton, & Reid, 2005), as well as less 
physical aggression, better peer ratings, and fewer police contacts (Walker et al., 1991). 
Moreover, comorbid internalizing symptoms confer partial protection from structural 
compromises in several brain structures among those with CD (Sauder, Beauchaine, Gatzke-
Kopp, Shannon, & Aylward, 2012).  
Even control participants—who were recruited for clear absence of symptoms—showed 
steep increases in depression from ages 8-15. In fact, by the Year 3 assessment, 29% met criteria 
for dysthymia or depression based on parent reports. Although it might be tempting to explain 
these findings away as a result of biased parent reporting or some other artifact, sensitivity and 
specificity of the CSI-4 mood disorder scales are strong, and the observed rate of depression, 
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although higher than that reported in the National Comorbidity Survey Replication Adolescent 
Supplement (Merikangas et al., 2010), is very close to that found in the National Longitudinal 
Study of Adolescent Health (Rushton et al., 2002). Thus, although growth in depression among 
non-psychiatric controls is concerning it is not atypical. 
Although CD symptoms expressed by the CPs group seemed to decline at age 14 (see Figure 
3), we purposefully do not interpret this for several reasons. First, sample size in any accelerated 
longitudinal study is smallest at age extremes. Furthermore, previous research shows that (1) 
early-onset CPs are unlikely to abate by mid-adolescence (e.g., Moffitt, 1993), and (2) parents 
know less about their children’s externalizing behaviors in adolescence than in middle school 
(see De Los Reyes & Kazdin, 2005). Unfortunately, this sample is no longer being followed so 
we cannot address this issue with more data.  
Limitations 
A primary limitation of this study is sole reliance on parent-report data using symptom 
checklists. As noted above, both the CSI and CBCL demonstrate strong reliability and validity. 
Nevertheless, structured clinical interviews would have strengthened our findings. Moreover, 
although parents become slightly poorer informants as their children age (see above; De Los 
Reyes & Kazdin, 2005; Edelbrock, Costello, Dulcan, Kalas, & Conover, 1985), this would cause 
under-reporting of symptoms over time, and therefore cannot explain increases in depression 
seen in all groups. We also relied on a single informant—a further limitation.  
In addition, with three time points, we could not assess non-linear trends in emerging CD or 
depression given our objective of evaluating within-person growth trajectories. Although most 
growth trajectories appear to be near-linear (see Figs. 2-4), quadratic analyses may have been 
especially useful to assess patterns of growth in both CD and depression. Furthermore, since we 
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used an accelerated longitudinal design, there were relatively few participants at age extremes. 
We should be careful, for example, in making inferences about non-linear growth based on 
apparent leveling off of depression among the CD group (see Figure 2). 
Conclusion 
Depression and CD co-occur significantly more often than expected by chance, which may 
suggest shared etiology. In attempts to elucidate etiology and devise more effective treatments, 
several research groups have sought to determine which disorder precedes the other. To date, 
most analyses have evaluated lagged associations across time points in attempts to establish 
temporal precedence of CD versus depression via statistical control. As we note above however, 
statistical partialling has several limitations when disentangling comorbidity and continuity in 
psychopathology. In this study, we recruited relatively ‘pure’ groups who were vulnerable to CD, 
depression, or both based on high levels of symptoms. Our findings indicate that CPs alone are 
associated with normative increases in depression throughout childhood and adolescence. In 
contrast, depression alone is not associated with development of CPs. Notably, however, all 
groups showed steep growth in depressive symptoms from ages 8-15 years. We hope future 
research elucidates specific mechanisms of shared vulnerability to CPs and depression—both 
biological and psychological (e.g., Carver et al., 2017; Tackett et al., 2013; Zisner & Beauchaine, 
2016)—as we seek to develop more effective prevention and intervention programs.  
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Table 1 












Notes. MDD=major depressive disorder; DYS=dysthymia; CD=conduct disorder; ODD=oppositional defiant disorder. 








Percent male          47.1          66.7          78.6         75.3 
Variable 
 
















Age at Time 1 9.83 1.52 10.22 1.48   9.54 1.60   9.95 1.46 
Child Symptom Inventory         
    MDD symptom severity 0.70 1.01 6.56 3.43   2.82 2.82 10.22 4.92 
    MDD symptom count 0.03 0.17 1.56 1.53   0.21 0.79   2.72 2.16 
    DYS symptom severity 0.93 1.11 7.00 2.27   2.93 1.90   9.74 4.04 
    DYS symptom count 0.03 0.17 2.26 1.23   0.36 0.49   2.98 1.94 
    CD symptom severity 0.67 1.01 1.44 1.48   7.07 5.07   7.40 4.69 
    CD symptom count 0.03 0.17 0.15 0.36   1.86 1.90   1.80 1.91 
    ODD symptom severity 4.00 2.96 7.37 3.44 16.32 4.06 17.04 4.64 
    ODD symptom count 0.27 0.66 1.56 1.67   5.79 1.83   5.95 2.14 
Child Behavior Checklist         
    anxious/depressed (T) 52.80 3.61 74.37 7.47 66.75 8.61 81.56 8.34 
    aggression (T) 51.16 2.38 57.04 5.81 77.64 8.90 79.65 9.16 
Running head: HOMOTYPIC AND HETEROTYPIC COMORBIDITY AND CONTINUITY 31	
Table 2  
Symptom Severity and Percentages of Participants Meeting Diagnostic Thresholds for Major Depression and/or Dysthymia* by  
Group Over Time 
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 SD 
% meeting  
criteria 
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    SD 
% meeting  
criteria 
 
    M 
 
   SD 
% meeting  
criteria 
          
Control     0.70    1.01            0.0%    9.96    1.54           23.5%   10.66    2.60          29.0% 
Depressed     6.56    3.43          85.2%  12.81    3.25           68.0%   13.13    4.01          73.9% 
Conduct     2.82    2.82            0.0%  12.81    3.59           76.9%   13.64    3.84          61.9% 
Comorbid   10.22    4.92          79.0%  14.59    4.49           82.6%   16.13    4.99          73.7% 
 




HOMOTYPIC AND HETEROTYPIC COMORBIDITY AND CONTINUITY  32 
Table 3  
Symptom Severity and Percentages of Participants Meeting Diagnostic Thresholds for Conduct Disorder by Group Over Time 
 
 Time 1 Time 2 Time 3 
 





  M 
 




   
 
  M 
 









Control 0.67 1.07   0.0% 0.43 0.94   4.4% 0.82 1.29  4.8% 
Depressed 1.44 1.48   0.0% 0.97 1.45 20.0% 1.33 1.78 12.5% 
Conduct 7.07 5.07 42.9% 4.12 3.55 42.9% 5.27 4.07 68.2% 
Comorbid 7.40 4.69 38.3% 3.96 3.04 56.5% 4.93 3.73 64.9% 
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Table 4. Summary of Fixed Slope and Uncentered Intercept Effects from Multilevel Models 
Variable coefficient   standard error t-statistic     p-value 
Predicting MDD symptom severity   
   For Intercept 1   
Intercept 2 0.105 0.936 0.112 .911 
sex 0.263 0.280 0.936 .351 
C1 0.006 0.001 4.540 <.001 
C2 -0.007 0.002 -3.090 .003 
C3 0.013 0.009 1.454 .147 
age at study entry -0.317 0.096 -3.291 .002 
   For Age slope     
Intercept 2 0.417 0.090 4.619 <.001 
sex -0.035 0.027 -1.302 .195 
C1 <-0.001 <0.001 -2.580 .011 
C2 <0.001 <0.001 1.900 .058 
C3 -0.001 <0.001 -1.186 .238 
age at study entry -0.003 0.009 -0.353 .724 
Predicting CD symptom severity    
   For Intercept 1     
Intercept 2 0.205 5.936 0.035 .973 
sex 1.316 1.713 0.769 .443 
C1 0.044 0.007 6.514 <.001 
C2 -0.155 0.016 -2.755 .007 
C3 -0.155 0.055 -2.835 .006 
age at study entry 0.869 0.618 1.407 .161 
   For Age slope     
Intercept 2 -0.301 0.529 -0.568 .571 
sex -0.196 0.164 -1.192 .235 
C1 -0.002 <0.001 -2.932 .004 
C2 0.003 0.001 2.030 .043 
C3 0.007 0.004 1.296 .197 
age at study entry -0.020 0.052 -0.228 .735 
Predicting ODD symptom severity    
   For Intercept 1     
Intercept 2 5.751 8.939 0.643 .520 
sex -1.873 2.740 -0.684 .495 
C1 0.091 0.013 6.806 <.001 
C2 -0.068 0.023 -2.986 .004 
C3 -0.258 0.087 -2.945 .004 
age at study entry -1.236 0.918 -1.347 .180 
   For Age slope     
Intercept 2 2.830 0.841 3.366 .001 
sex 0.018 0.257 0.069 .946 
C1 -0.005 0.001 -4.282 <.001 
C2 0.004 0.002 1.923 .056 
C3 0.013 0.008 1.661 .098 
age at study entry -0.088 0.082 -1.066 .288 
 
Table notes. Degrees of freedom were 200 for all t-tests. C1=Contrast 1 (all clinical groups vs. healthy 
controls); C2=Contrast 2 (comorbid group vs. depressed and conduct problems groups); C3=Contrast 3 
(depressed vs. conduct problems groups). 
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Figure 1. Effects of using statistical partialling techniques (e.g., ANCOVA, hierarchical regression, lag correlational designs) to evaluate 
heterotypic continuity of traits with shared etiologies. The left panel depicts the concurrent correlation (comorbidity) between depression 
and conduct problems (CPs) at age 8. The right panel depicts prospective prediction of CPs at age 12 by depression at age 8, controlling 
for CPs at age 8. Statistical partialling removes shared vulnerability (A in both the left and right panels), which (1) creates statistical 
entities (depression without vulnerability to CPs, CPs without vulnerability to depression) that misrepresent/distort etiological relations 
between disorders, and (2) under-estimate longitudinal associations by artificially attenuating common variance among predictors and 
outcomes (C, right panel). Despite recognition of these issues for decades (see Pedhazur, 1997), partialling procedures remain common in 
the psychopathology literature. Contrasted groups designs do not rely on statistical partialling and therefore offer advantages over 
research conducted with only comorbid samples. 
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Figure 2. Growth in depressive symptoms by group from ages 8-14 years. Age 15 data are 
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Figure 3. Growth in conduct disorder symptoms by group from ages 8-14 years. Age 15 data are 
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Figure 4. Growth in oppositional defiant disorder symptoms by group from ages 8-14 years. Age 
15 data are omitted because only 13 participants were distributed across the four groups, so 
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